Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)

INTRODUCTION: Inadequate antibody response to mRNA SARS-CoV-2 vaccination has been described among kidney transplant recipients. Immunosuppression level and specifically, use of antimetabolite in the maintenance immunosuppressive regimen, are associated with inadequate response. In light of the seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahav, Dafna, Rozen-Zvi, Benaya, Mashraki, Tiki, Atamna, Alaa, Ben-Zvi, Haim, Bar-Haim, Erez, Rahamimov, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506046/
https://www.ncbi.nlm.nih.gov/pubmed/34635537
http://dx.doi.org/10.1136/bmjopen-2021-055611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506046/
https://www.ncbi.nlm.nih.gov/pubmed/34635537
http://dx.doi.org/10.1136/bmjopen-2021-055611

Ejemplares similares